• 1
    Robson B, Cormack D, Purdie G. Unequal Impact: Maori and Non-Maori Cancer Statistics 1996-2001. Wellington, New Zealand: Ministry of Health; 2006.
  • 2
    Jeffreys M, Stevanovic V, Tobias M, et al. Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health. 2005; 95: 834-837.
  • 3
    Valery PC, Coory M, Stirling J, Green AC. Cancer diagnosis, treatment, and survival in indigenous and non-indigenous Australians: a matched cohort study. Lancet. 2006; 367: 1842-1848.
  • 4
    Condon JR, Armstrong BK, Barnes T, Cunningham J. Cancer in indigenous Australians: a review. Cancer Causes Control. 2003; 14: 109-121.
  • 5
    Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004; 101: 3-27.
  • 6
    Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78-93.
  • 7
    Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334-357.
  • 8
    SmedleyB, StithA, NelsonA, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academic Press; 2002.
  • 9
    Stevens W, Stevens G, Kolbe J, Cox B. Ethnic differences in the management of lung cancer in New Zealand. J Thorac Oncol. 2008; 3: 237-244.
  • 10
    American Cancer Society. Colorectal Cancer Facts and Figures 2008-2010. Atlanta, Ga: American Cancer Society; 2008.
  • 11
    Parkin D, Bray F, Ferlay L, Pisani P. Global cancer statistics 2002. CA Cancer J Clin. 2005; 55: 74-108.
  • 12
    Shaw C, Blakely T, Sarfati D, Fawcett J, Peace J. Trends in colorectal cancer mortality by ethnicity and socio-economic position in New Zealand, 1981-99: 1 country, many stories. Aust NZ J Public Health. 2006; 30: 64-70.
  • 13
    Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001; 93: 583-596.
  • 14
    Otchy D, Hyman NH, Simmang C, et al. Practice parameters for colon cancer. Dis Colon Rectum. 2004; 47: 1269-1284.
  • 15
    National Institutes of Health. NIH consensus conference: adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264: 1444-1450.
  • 16
    Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. BMJ. 2000; 321: 531-535.
  • 17
    Demissie K, Oluwole OO, Balasubramanian BA, Rhoads GG. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between whites and blacks. Ann Epidemiol. 2004; 14: 215-221.
  • 18
    Ball J, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care. 1996; 34: 970-984.
  • 19
    Cooper GS, Yuan Z, Landefeld CS, Rimm AA. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health. 1996; 86: 582-586.
  • 20
    Baldwin L-M, Dobie S, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005; 97: 1211-1220.
  • 21
    Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005; 294: 2703-2711.
  • 22
    Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant chemotherapy for colorectal cancer. J Clin Oncol. 2002; 20: 1192-1202.
  • 23
    Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol. 2002; 20: 3999-4005.
  • 24
    GreeneFL, PageDL, FlemmingID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
  • 25
    Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007; 99: 433-441.
  • 26
    Chau I, Norman AR, Cunningham D, et al. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol. 2005; 16: 549-557.
  • 27
    Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162: 199-200.
  • 28
    Sarfati D, Hill S, Blakely T, et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study [serial online]. BMC Cancer. 2009; 9: 116.
  • 29
    New Zealand Ministry of Health. A Portrait of Health: Key Results of the 2002/03 New Zealand Health Survey. Wellington, New Zealand: New Zealand Ministry of Health; 2004.
  • 30
    Sadler L, Priest P, Peters J, Crengle S, Jackson R. The New Zealand Cervical Cancer Audit. Wellington, New Zealand: New Zealand Ministry of Health; 2004.
  • 31
    Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 2nd ed. London, United Kingdom: Association of Coloproctology of Great Britain and Ireland; 2001.
  • 32
    Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 3rd ed. London, United Kingdom: Association of Coloproctology of Great Britain and Ireland; 2007.
  • 33
    Davis P, Lay-Yee L, Briant R, Sporle A, Brunt D, Scott A. Quality of hospital care for Maori patients in New Zealand: retrospective cross-sectional assessment. Lancet. 2006; 367: 1920-1925.
  • 34
    Jong K, Vale P, Armstrong BK. Rural inequalities in cancer care and outcome. Med J Aust. 2005; 182: 13-14.
  • 35
    Blustein J. Who is accountable for racial equity in health care? JAMA. 2008; 299: 814-816.
  • 36
    Jha A, Orav E, Li Z, Epstein A. Concentration and quality of hospitals that care for elderly black Americans. Arch Intern Med. 2007; 167: 1177-1182.
  • 37
    Skinner J, Chandra A, Staiger D, Lee J, McClellan M. Mortality after acute myocardial infarction in hospitals that disproportionately treat Black patients. Circulation. 2005; 112: 2634-2641.
  • 38
    Hasnain-Wynia R, Baker DW, Nerenz D, et al. Disparities in health care are driven by where minority patients seek care. Arch Intern Med. 2007; 167: 1233-1239.
  • 39
    Barnato AE, Lucas FL, Staiger D, Wennberg DE, Chandra A. Hospital-level racial disparities in acute myocardial infarction treatment and outcomes. Med Care. 2005; 43: 308-318.
  • 40
    Bach PB, Pharm HH, Schrag D, Tate RC, Hargraves L. Primary care physicians who treat blacks and whites. N Engl J Med. 2004; 351: 575-584.
  • 41
    Bailey JE, Sprabery LR. Inequitable funding may cause health care disparities [editorial]. Arch Intern Med. 2007; 167: 1226-1228.
  • 42
    Kressin NR. Separate but not equal: the consequences of segregated health care [editorial]. Circulation. 2005: 112: 2582-2584.
  • 43
    Harris R, Tobias M, Jeffreys M, Waldegrave K, Karlson S, Nazroo J. Effects of self-reported racial discrimination and deprivation on Maori health and inequalities in New Zealand: cross-sectional study. Lancet. 2006; 367: 2005-2009.
  • 44
    Cunningham R, Sarfati D, Hill S, Kenwright D. An audit of colon cancer data on the New Zealand Cancer Registry. NZ Med J. 2008; 121: 46-56.